Lin BioScience (ROCO:6696) Research & Development: NT$1,612.54 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6696 Lin BioScience Inc ROCO:6696
26 GF Score
Price NT$698.00
! 3 Warning Signs
View Full Analysis

What is Lin BioScience Research & Development?

Lin BioScience ROCO:6696 -6.18% 26 Research & Development is NT$1,612.54 Mil as of Dec. 2025. GuruFocus rates ROCO:6696 with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Lin BioScience's Research & Development for the six months ended in Dec. 2025 was NT$878.82 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1,612.54 Mil.

Lin BioScience  (ROCO:6696) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lin BioScience Research & Development Related Terms

Lin BioScience Research & Development Historical Data

* Premium members only.

The historical data trend for Lin BioScience's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lin BioScience Research & Development Chart

Lin BioScience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 244.76 320.87 854.07 1,101.12 1,612.54

Lin BioScience Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 487.70 530.72 570.40 733.72 878.82
ROCO:6696
26GF Score
Lin BioScience Inc ROCO:6696
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lin BioScience Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$1,612.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$1,612.54 Mil mean?
Lin BioScience (ROCO:6696) has a Research & Development of NT$1,612.54 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Lin BioScience and its competitors.
Is Lin BioScience's Research & Development too high?
Lin BioScience's current Research & Development is NT$1,612.54 Mil. Overall, Lin BioScience has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Lin BioScience's Research & Development compare to VRTX and REGN?
Lin BioScience's Research & Development of NT$1,612.54 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Lin BioScience and its competitors. Lin BioScience's current Research & Development is NT$1,612.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lin BioScience stock overvalued right now?
Lin BioScience (ROCO:6696) has a current Research & Development of NT$1,612.54 Mil. The current Research & Development is NT$1,612.54 Mil. Lin BioScience's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Lin BioScience (ROCO:6696), the current Research & Development is NT$1,612.54 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lin BioScience Business Description

Address Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.
26GF Score

Get the complete analysis for ROCO:6696

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$698.00
Price